Onkologi
Menerima Anemia Normovolemik
Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (terbuka di window baru)
Sumber: Gynecol Oncol 2014;132(1):227-30.
Index: PubMed 24512847
DOI: 10.1016/j.ygyno.2013.10.019
https://www.ncbi.nlm.nih.gov/pubmed/24512847 (terbuka di window baru)
Liberal or restrictive transfusion in high-risk patients after hip surgery. (terbuka di window baru)
Sumber: N Engl J Med 2011;365(26):2453-62.
Index: PubMed 22168590
DOI: 10.1056/NEJMoa1012452
https://www.ncbi.nlm.nih.gov/pubmed/22168590 (terbuka di window baru)
Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (terbuka di window baru)
Sumber: Transfusion 2016;56(10):2438-42.
Index: PubMed 27385671
DOI: 10.1111/trf.13703
https://www.ncbi.nlm.nih.gov/pubmed/27385671 (terbuka di window baru)
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (terbuka di window baru)
Sumber: J Clin Oncol 2015;33(15):1674-9.
Index: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
https://www.ncbi.nlm.nih.gov/pubmed/25870085 (terbuka di window baru)
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (terbuka di window baru)
Sumber: Transfus Med Rev 2002;16(1):34-45.
Index: PubMed 11788928
https://www.ncbi.nlm.nih.gov/pubmed/11788928 (terbuka di window baru)
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (terbuka di window baru)
Sumber: N Engl J Med 1999;340(6):409-17.
Index: PubMed 9971864
DOI: 10.1056/NEJM199902113400601
https://www.ncbi.nlm.nih.gov/pubmed/9971864 (terbuka di window baru)
Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (terbuka di window baru)
Sumber: Intensive Care Med 2013;39(3):445-53.
Index: PubMed 23184038
DOI: 10.1007/s00134-012-2757-z
https://www.ncbi.nlm.nih.gov/pubmed/23184038 (terbuka di window baru)
How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (terbuka di window baru)
Sumber: Cancer Treat Rev 2016;46:1-8.
Index: PubMed 27046422
DOI: 10.1016/j.ctrv.2016.03.010
https://www.ncbi.nlm.nih.gov/pubmed/27046422 (terbuka di window baru)
Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (terbuka di window baru)
Sumber: Transfusion 2014;54(10 Pt 2):2678-86.
Index: PubMed 25135770
DOI: 10.1111/trf.12825
https://www.ncbi.nlm.nih.gov/pubmed/25135770 (terbuka di window baru)
Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (terbuka di window baru)
Sumber: J Clin Oncol 2020;38(13):1463-73.
Index: PubMed 32083994
DOI: 10.1200/JCO.19.01836
https://www.ncbi.nlm.nih.gov/pubmed/32083994 (terbuka di window baru)
Transfusion indications for patients with cancer. (terbuka di window baru)
Sumber: Cancer Control 2015;22(1):38-46.
Index: PubMed 25504277
https://www.ncbi.nlm.nih.gov/pubmed/25504277 (terbuka di window baru)
Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (terbuka di window baru)
Sumber: Am J Surg 2015;210(6):1197-204.
Index: PubMed 26602534
DOI: 10.1016/j.amjsurg.2015.08.013
https://www.ncbi.nlm.nih.gov/pubmed/26602534 (terbuka di window baru)